Analysen von Jo Walton
| 20.12.24 | Novo Nordisk Neutral | UBS AG | |
| 16.12.24 | Novo Nordisk Neutral | UBS AG | |
| 09.12.24 | Novo Nordisk Neutral | UBS AG | |
| 02.12.24 | Novo Nordisk Neutral | UBS AG | |
| 21.11.24 | Bayer Neutral | UBS AG | |
| 18.11.24 | Novo Nordisk Neutral | UBS AG | |
| 13.11.24 | Bayer Neutral | UBS AG | |
| 13.11.24 | Novo Nordisk Neutral | UBS AG | |
|
Werbung
|
|||
| 12.11.24 | Bayer Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Neutral | UBS AG | |
| 07.11.24 | Novo Nordisk Neutral | UBS AG | |
| 07.11.24 | Bayer Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 04.11.24 | Novo Nordisk Neutral | UBS AG | |
| 31.10.24 | GSK Neutral | UBS AG | |
| 30.10.24 | GSK Neutral | UBS AG | |
| 28.10.24 | Novo Nordisk Neutral | UBS AG | |
| 28.10.24 | Sanofi Buy | UBS AG | |
| 25.10.24 | Sanofi Buy | UBS AG | |
| 21.10.24 | Sanofi Buy | UBS AG | |
| 21.10.24 | GSK Neutral | UBS AG | |
| 17.10.24 | Sanofi Buy | UBS AG | |
| 15.10.24 | Novo Nordisk Neutral | UBS AG | |
| 10.10.24 | GSK Neutral | UBS AG | |
| 03.10.24 | Novo Nordisk Neutral | UBS AG | |
| 20.09.24 | Novo Nordisk Neutral | UBS AG | |
| 11.09.24 | Novo Nordisk Neutral | UBS AG | |
| 02.09.24 | Bayer Neutral | UBS AG | |
| 09.08.24 | Novo Nordisk Neutral | UBS AG | |
| 07.08.24 | Bayer Neutral | UBS AG | |
| 07.08.24 | Novo Nordisk Neutral | UBS AG | |
| 06.08.24 | Bayer Neutral | UBS AG | |
| 02.08.24 | Bayer Neutral | UBS AG | |
| 01.08.24 | Novo Nordisk Neutral | UBS AG | |
| 01.08.24 | GSK Neutral | UBS AG | |
| 26.07.24 | Sanofi Buy | UBS AG | |
| 09.07.24 | Sanofi Buy | UBS AG | |
| 08.07.24 | GSK Neutral | UBS AG | |
| 04.07.24 | GSK Buy | UBS AG | |
| 28.06.24 | Novo Nordisk Neutral | UBS AG | |
| 27.06.24 | GSK Buy | UBS AG | |
| 25.06.24 | Sanofi Buy | UBS AG | |
| 18.06.24 | GSK Buy | UBS AG | |
| 04.06.24 | GSK Buy | UBS AG | |
| 04.06.24 | Sanofi Buy | UBS AG | |
| 17.05.24 | Bayer Neutral | UBS AG | |
| 15.05.24 | Bayer Neutral | UBS AG | |
| 15.05.24 | Novo Nordisk Neutral | UBS AG | |
| 14.05.24 | Novo Nordisk Neutral | UBS AG | |